Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVIRS: Gut Microbiota and Immune Responses to Vaccination
NCT06148025Phase 4Recruiting
- Sponsor
- South Australian Health and Medical Research Institute
- Start
- Nov 2023
- Primary completion
- Oct 2027
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine, 17D yellow fever vaccine, vancomycin, neomycin, sponsored by South Australian Health and Medical Research Institute. Started Nov 2023; status: recruiting.
02
Drugs
bcg vaccine17D yellow fever vaccinevancomycinneomycin
Beyond the preview
Go deeper on NCT06148025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06148025.